PHARMACOKINETICS AND HEMODYNAMIC-EFFECTS OF LONG-TERM NIFEDIPINE TREATMENT IN HYPERTENSIVE PATIENTS

被引：29

作者：

KLEINBLOESEM, CH

VANBRUMMELEN, P

FABER, H

BREIMER, DD

机构：

[1] STATE UNIV LEIDEN,HOSP,DEPT NEPHROL,BLDG B4-Q78,POB 9600,2312 AV LEIDEN,NETHERLANDS

[2] STATE UNIV LEIDEN,DIV PHARMACOL,CTR BIOPHARMACEUT SCI,SYLVIUS LABS,2312 AV LEIDEN,NETHERLANDS

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1987年 / 9卷 / 02期

关键词：

D O I：

10.1097/00005344-198702000-00012

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：202 / 208

页数：7

相关论文

共 20 条

[1] ANTIHYPERTENSIVE EFFECT OF CARDIOVASCULAR CA2+-ANTAGONIST IN HYPERTENSIVE PATIENTS IN ABSENCE AND PRESENCE OF BETA-ADRENERGIC-BLOCKADE
AOKI, K
KONDO, S
MOCHIZUKI, A
YOSHIDA, T
KATO, S
KATO, K
TAKIKAWA, K
[J]. AMERICAN HEART JOURNAL, 1978, 96 (02) : 218 - 226
[2] ACUTE AND LONG-TERM HYPOTENSIVE EFFECTS AND PLASMA-CONCENTRATIONS OF NIFEDIPINE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
AOKI, K
SATO, K
KAWAGUCHI, Y
YAMAMOTO, M
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 23 (03) : 197 - 201
[3] BARR AJ, 1979, STATISTICAL ANAL SYS
[4] NIFEDIPINE IN THE TREATMENT OF HYPERTENSION - REPORT OF A DOUBLE-BLIND CONTROLLED TRIAL
BAYLEY, S
DOBBS, RJ
ROBINSON, BF
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (04) : 509 - 512
[5] BIANCHETTI MG, 1983, HYPERTENSION S2, V5, P56
[6] BUHLER FR, 1984, 2ND P WORLD C CLIN P, P800
[7] EVANS GH, 1973, CLIN PHARMACOL THER, V14, P487
[8] NIFEDIPINE INCREASES AND GLYCERYL TRINITRATE DECREASES APPARENT LIVER BLOOD-FLOW IN NORMAL SUBJECTS
FEELY, J
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (01) : 83 - 85
[9] GIBALDI M, 1982, PHARMACOKINETICS
[10] GUAZZI M, 1977, CLIN PHARMACOL THER, V22, P528